Products Used in Cancer Treatment Research Produced in Inchinnan

Essential products needed for the production of biotherapeutics and vaccines for diseases such as influenza, Ebola and cancer will be produced in Scotland, following the launch of the new state-of-the-art facility near Glasgow.

The new facility will add to the Inchinnan site’s existing manufacturing operations, which produce liquid media for a range of research and production applications.

The new site is the only one of its kind in Europe and only the second in the world. The other is in Grand Island, New York.

Thermo Fisher Scientific, the world leader in serving science, has expanded its campus in Inchinnan with the addition of a cutting-edge facility that will manufacture a novel and proprietary dry media powder known as Gibco™ Advanced Granulation Technology (AGT).

The AGT dry media format reduces the number of components necessary in cell culture manufacturing processes which is used to manufacture biologics, including vaccines, anti-cancer therapeutics and other life-saving drugs.

The £14 million investment increases the assurance of supply for customers and complements another Thermo Fisher facility in Grand Island, New York, where AGT is also manufactured.

Mark Smedley, President of Europe, Middle East and Africa, Life Sciences Solutions, for Thermo Fisher said: “This is a strategically important facility that will secure supplies for our target markets all over the world.

“It’s important to choose the right location for a factory of this significance, and we felt the depth of experience, skills and expertise at Inchinnan made it the perfect place to make this investment.”

This investment is linked to on-going support from Scottish Enterprise to assist Thermo Fisher in expanding the company’s global manufacturing network.

Paul Lewis, Managing Director, Scottish Development International and Scottish Enterprise International Operations said: "Congratulations to Thermo Fisher on the opening of their impressive new facility at Inchinnan.

"Scotland is already home to a thriving life sciences cluster which is recognised worldwide as one of the most accessible, well-connected and collaborative in Europe. It is major investments like this that allow us to continue to attract ambitious, international companies such as Thermo Fisher to not only locate in Scotland but to strengthen their business base here and to invest in long-term growth."